Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tilg

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
Current Medicinal Chemistry|August 11, 2012
Adiponectin: key player in the adipose tissue-liver crosstalkA R Moschen, V Wieser, H Tilg
European Journal of Clinical Investigation|August 22, 2006
Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis CW Grander, P Eller, R Fuschelberger, et al.
Immunology Today|September 18, 1997
IL-6 and APPs: anti-inflammatory and immunosuppressive mediatorsH Tilg, C A Dinarello, J W Mier
Wiener Klinische Wochenschrift|January 23, 2002
Infliximab in severe steroid-refractory ulcerative colitis: a pilot studyA Kaser, T Mairinger, W Vogel, et al.
Lancet (London, England)|March 16, 1991
Stress proteins and myocardial protection: is there a role for tumour necrosis factor?H Tilg, J Mair, M Herold, et al.
Lancet (London, England)|May 5, 1999
Interferon-beta 1b augments activation-induced T-cell death in multiple sclerosis patientsA Kaser, F Deisenhammer, T Berger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 24, 2007
Cheilitis granulomatosa and Melkersson-Rosenthal syndrome: evaluation of gastrointestinal involvement and therapeutic regimens in a series of 14 patientsG Ratzinger, N Sepp, W Vogetseder, et al.
Lancet (London, England)|October 13, 2001
A woman with vomiting and depressionC Molnar, M Lechleitner, G Wetscher, et al.
Digestive Diseases (Basel, Switzerland)|November 20, 2013
Targeting T and B lymphocytes in inflammatory bowel diseases: lessons from clinical trialsR R Gerner, A R Moschen, H Tilg
Padiatrie Und Padologie|January 1, 1989
[Diagnosis and therapeutic strategies in pneumonia in childhood]R Schmitzberger, J P Guggenbichler, H Tilg, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Current Medicinal Chemistry|August 11, 2012
Adiponectin: key player in the adipose tissue-liver crosstalkA R Moschen, V Wieser, H Tilg
European Journal of Clinical Investigation|August 22, 2006
Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis CW Grander, P Eller, R Fuschelberger, et al.
Immunology Today|September 18, 1997
IL-6 and APPs: anti-inflammatory and immunosuppressive mediatorsH Tilg, C A Dinarello, J W Mier
Wiener Klinische Wochenschrift|January 23, 2002
Infliximab in severe steroid-refractory ulcerative colitis: a pilot studyA Kaser, T Mairinger, W Vogel, et al.
Lancet (London, England)|March 16, 1991
Stress proteins and myocardial protection: is there a role for tumour necrosis factor?H Tilg, J Mair, M Herold, et al.
Lancet (London, England)|May 5, 1999
Interferon-beta 1b augments activation-induced T-cell death in multiple sclerosis patientsA Kaser, F Deisenhammer, T Berger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 24, 2007
Cheilitis granulomatosa and Melkersson-Rosenthal syndrome: evaluation of gastrointestinal involvement and therapeutic regimens in a series of 14 patientsG Ratzinger, N Sepp, W Vogetseder, et al.
Lancet (London, England)|October 13, 2001
A woman with vomiting and depressionC Molnar, M Lechleitner, G Wetscher, et al.
Digestive Diseases (Basel, Switzerland)|November 20, 2013
Targeting T and B lymphocytes in inflammatory bowel diseases: lessons from clinical trialsR R Gerner, A R Moschen, H Tilg
Padiatrie Und Padologie|January 1, 1989
[Diagnosis and therapeutic strategies in pneumonia in childhood]R Schmitzberger, J P Guggenbichler, H Tilg, et al.
Pageof 15